Document is current
Any future updates will be listed below
-
Authors
Goldring, Christopher E. https://orcid.org/0000-0002-8951-2226
Russomanno, Giusy https://orcid.org/0000-0002-3378-5524
Pin, Carmen https://orcid.org/0000-0001-8734-6167
Trairatphisan, Panuwat https://orcid.org/0000-0001-9015-5855
Beattie, Kylie A. https://orcid.org/0000-0002-8579-6321
Fisher, Ciarán P.
Piñero, Janet https://orcid.org/0000-0003-1244-7654
Brennan, Richard J.
Clausznitzer, Diana
Copple, Ian M.
de Kok, Theo M. https://orcid.org/0000-0003-2102-3626
Duckworth, Carrie A.
Furlong, Laura I.
Füzi, Barbara
Gabor, Attila
Gall, Louis https://orcid.org/0000-0002-1805-2357
Hengstler, Jan https://orcid.org/0000-0002-1427-5246
Hermjakob, Henning https://orcid.org/0000-0001-8479-0262
Hunter, Fiona https://orcid.org/0000-0001-7160-1880
Jennen, Danyel https://orcid.org/0000-0002-8618-2487
Koskinen, Mikko https://orcid.org/0000-0003-2033-051X
Kunnen, Steven J. https://orcid.org/0000-0001-9549-1719
Lammens, Lieve
Lobentanzer, Sebastian https://orcid.org/0000-0003-3399-6695
Mohr, Marcel https://orcid.org/0000-0001-6553-8651
Passini, Elisa https://orcid.org/0000-0003-0116-6347
Pritchard, D. Mark https://orcid.org/0000-0001-7971-3561
Malik-Sheriff, Rahuman S.
Rodríguez, Blanca
Rossman, Eric I.
Saez-Rodríguez, Julio https://orcid.org/0000-0002-8552-8976
Schmidt, Friedemann https://orcid.org/0000-0003-0265-0974
Sison-Young, Rowena
Soininen, Inari https://orcid.org/0000-0002-2428-5245
Turner, Sean
van de Water, Bob
van Hasselt, Johan G. C. https://orcid.org/0000-0002-1664-7314
Venezia, Filippo
Willy, Jeffrey A.
Leishman, Derek J.
Stevens, James L.
Laplanche, Loic https://orcid.org/0000-0002-6082-9430
- License Information
-
More Information
Article History
Accepted: 17 September 2025
First Online: 27 October 2025
Competing interests
: C.P. and L.G. are employees and shareholders of AstraZeneca. K.A.B., C.P.F. and E.I.R. are employees of GSK. F.S., M.M. and P.T. are employees and shareholders, and R.J.B. is a retired employee and shareholder of Sanofi. D.C., S.T. and L.L. are employees and shareholders of AbbVie. M.K. is an employee of Orion Corporation. L.L. is a shareholder of Johnson & Johnson. J.S.-R. reports in the past 3 years funding from GSK and Pfizer and fees or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, Grunenthal, Tempus and Moderna. F.V. is an employee of Servier. J.A.W. is an employee of Vertex Pharmaceuticals. D.J.L. is an employee of Eli Lilly and Company. All other authors declared no competing interests for this work.
